Method 525 Standard Mix 3 (High Concentration) Agilent Part Number 8500-5936

SECTION 2: Hazards identification

29 CFR 1910.1200) Physical state Liquid. Odor : Minty. OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200).

Signal word

WARNING!

Hazard statements

FLAMMABLE LIQUID AND VAPOR. INHALATION CAUSES HEADACHES, DIZZINESS, DROWSINESS AND NAUSEA AND MAY LEAD TO UNCONSCIOUSNESS. CAUSES RESPIRATORY TRACT AND EYE IRRITATION. MAY CAUSE SKIN IRRITATION. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA.

Precautionary statements

Keep away from heat, sparks and flame. Do not breathe vapor or mist. Do not get in eyes. Avoid contact with skin and clothing. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling.

Principle Routes of Exposure

Dermal contact. Eye contact. Inhalation. Ingestion.

Potential Acute Health Effects

Inhalation Can cause central nervous system (CNS) depression. Irritating to respiratory system. Ingestion Can cause central nervous system (CNS) depression. Skin Slightly irritating to the skin. Eyes Severely irritating to eyes. Risk of serious damage to eyes.

Potential chronic health

effects : Contains material that may cause target organ damage, based on animal data. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.

Teratogenic Effects

No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: upper respiratory tract, skin, central nervous system (CNS), eye, lens or cornea. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: nausea or vomiting respiratory tract irritation coughing headache drowsiness/fatigue dizziness/vertigo unconsciousness Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Pre-existing disorders involving any target organs mentioned in this MSDS as being at aggravated by over- risk may be aggravated by over-exposure to this product. exposure See toxicological information (section 11)